Determinants of disability in alzheimer's disease
β Scribed by Orazio Zanetti; Angelo Bianchetti; Giovanni B. Frisoni; Renzo Rozzini; Marco Trabucchi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 488 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The aim of the study is to evaluate risk factors of disability in a population of 64 patients affected by Alzheimer's disease. The subjects were consecutively recruited at the day hospital service of an Alzheimer's dementia care unit. The associations between activities of daily living and age, cognitive status, affective status, cognitive symptoms duration and number of diseases were evaluated within a multidimensional assessment programme. Cognitive performance, as detected by the MiniβMental Status Examination, was the main independent predictor of disability; other independent predictors of disability were age and cognitive disease duration. Number of diseasesβphysical and mentalβand selfβrated depression scores were not independently associated with disability. It is concluded that, in a population of Alzheimer's patients, cognitive impairment has a high impact on the aetiology of disability, but other variables such as age and disease duration should be taken into account. It is also suggested that cognitive performance is the most important indicator of performance in activities of daily living.
π SIMILAR VOLUMES
## Background: Alzheimer's disease (ad), the most common cause of dementia, is a major cause of disability and care burden in the elderly. this study aims to estimate the costs of formal and informal care and identity determinants of care costs. ## Materials and methods: Two hundred and seventy-t
## Abstract Even with optimal therapy, it is inevitable that the symptoms of Parkinson's disease (PD) progress and gradually result in disability in the performance of daily activities. Delay and prevention of disability is among the highest priorities in the clinical management of PD. Understandin
## Abstract Ramon y Cajal proclaimed in 1928 that βonce development was ended, the founts of growth and regeneration of the axons and dendrites dried up irrevocably. In the adult centers the nerve paths are something fixed, ended and immutable. Everything must die, nothing may be regenerated. It is
Tetrahydroaminoacridine (THA), a centrally acting anticholinesterase, was used in a two-month, double-blind, placebo-controlled crossover trial to treat 10 patients meeting DSM-111-R criteria for dementia of the Alzheimer type. Eight patients continued to take THA for a further three months. Nausea